Antisense Oligonucleotide Design and Evaluation of Splice-Modulating Properties Using Cell-Based Assays

Area of Science:

• Molecular Biology
• Genetics
• Drug Discovery

Background:

• Antisense oligonucleotide (AON)-based splice modulation is a promising therapeutic strategy for hereditary diseases.
• AONs are single-stranded RNA or DNA molecules that bind to pre-mRNA splice sites, altering splicing events.
• The specificity of AONs allows for targeted application across various genes and genetic disorders.

Purpose of the Study:

• To provide a comprehensive guideline for establishing AON-based splice modulation experiments.
• To detail a protocol for designing and evaluating AONs.
• To combine in silico and in vitro analyses for robust AON assessment.

Main Methods:

• In silico design of AONs targeting specific splice sites.
• In vitro evaluation of AON efficacy in modulating splicing.
• Utilizing a combination of computational and experimental approaches.

Main Results:

• A detailed protocol for AON design and evaluation was established.
• The guideline integrates in silico and in vitro analyses for comprehensive assessment.
• The methodology facilitates the development of AON-based therapies.

Conclusions:

• AON-based splice modulation is a viable therapeutic strategy for genetic disorders.
• The provided guideline offers a robust framework for AON experiment design and evaluation.
• This approach aids in advancing the development of targeted genetic therapies.